PPT-Re-examining Metoclopramide’s Role in Prevention of Postoperative Nausea and/or Vomiting
Author : bety | Published Date : 2023-12-30
Amy Masiongale DNP CRNA Jane Garvin PhD APRN FNPBC Marguerite Murphy DNP RN Stephen W Looney PhD College of Nursing Georgia Regents University soon to be
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Re-examining Metoclopramide’s Role in ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Re-examining Metoclopramide’s Role in Prevention of Postoperative Nausea and/or Vomiting: Transcript
Amy Masiongale DNP CRNA Jane Garvin PhD APRN FNPBC Marguerite Murphy DNP RN Stephen W Looney PhD College of Nursing Georgia Regents University soon to be Augusta University Augusta. BIOL445- Biology of Toxins. Geanna. Capitan, Caleb Mangum, Patrick Quintana, . Gennifer. Smith. Why are Nausea and Vomiting . Important During Pregnancy?. Expels ingested pathogens, toxins, and possible teratogens. Stanford Anesthesia. PONV. Vanessa Moll, MD. Stanford Anesthesia. Among most common side effects of anesthesia. . Overall incidence of PONV for all surgeries and patient populations is estimated to be 25% to 30% (1). Dr . Hicham. Al . Mawla. . EMJ LEBANON . Definitions . Nausea : . Vague , unpleasant sensation that precedes vomiting , it may happen alone , with retching or vomiting , and shares the same pathway of vomiting but due less stimulation of that .. Dr. Lucy Harris. SpR. Palliative Medicine. September 2014. A Starting . Point - Definitions. Nausea:. An unpleasant sensation of the need to vomit, often accompanied by autonomic symptoms – sweating, salivation, tachycardia.. Antiemetic. Guideline 2016. Multinational . Association of . Supportive Care in . Cancer. Organizing . and Overall Meeting Chairs. :. Matti. . Aapro, MD. Richard . J. . Gralla. , . MD. Jørn. . Herrstedt. Mike Harlos MD, CCFP(PC), FCFP. Professor and Section Head, Palliative Medicine, University of Manitoba. Medical Director, WRHA Adult and Pediatric Palliative Care. http://palliative.info. Objectives. Nausea and Vomiting in Palliative Care Audit Presentation January 15 th 2015 Dr Richard Latten Dr Seamus Coyle Dr Laura McGlynn Dr Paula Powell Dr Jamie Barfield Ann Griffiths Sian Rae Agnes Noble Dr. Syed Md. . Basheeruddin. . Asdaq. Learning outcomes . At the end of lecture, students should be able to:. Enlist . the agents used as antiemetic and pro kinetic. Discuss the clinical uses, mechanism of action and adverse effects of 5HT3 Antagonist, D2 Antagonists, . SpR. Palliative Medicine. September 2014. A Starting . Point - Definitions. Nausea:. An unpleasant sensation of the need to vomit, often accompanied by autonomic symptoms – sweating, salivation, tachycardia.. Although nausea and vomiting occur in a variety of conditions (for example, motion sickness, pregnancy, and hepatitis) and are always unpleasant for the patient.. The nausea and vomiting produced by . Treatments that may cause nausea and vomitingPhysical reasons that may cause nausea and vomitingPossible side effects Clatterbridge Cancer Centre Hotline 0800 169 5555If you are unwell during or up to Courses in Therapeutics and Disease State Management. Learning Objectives (Slide 1 of 2). Describe the various etiologies of N/V. Discuss the pathophysiology of N/V. Compare and contrast simple and complex . . 1436 H. Pharmacology Department. College of Medicine. Learning objectives. Classify . the main different classes of antiemetic drugs according to their mechanism of action.. Know the characteristic pharmacokinetics & dynamics of different classes of antiemetic drugs.. PONV. Vanessa Moll, MD. Stanford Anesthesia. Among most common side effects of anesthesia. . Overall incidence of PONV for all surgeries and patient populations is estimated to be 25% to 30% (1). 0.18% risk of intractable PONV* -> delay in PACU discharge or unanticipated hospital admission -> increasing medical costs (2).
Download Document
Here is the link to download the presentation.
"Re-examining Metoclopramide’s Role in Prevention of Postoperative Nausea and/or Vomiting"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents